Call
Patient ReportsWhat Is Paraneoplastic Uveal Melanocytic Hyperplasia?
Written by Medicover Team and Medically Reviewed by Dr Kovvuru Bhaskar Reddy , Oncologists
Table of Contents
Paraneoplastic uveal melanocytic hyperplasia, more commonly referred to as bilateral diffuse uveal melanocytic proliferation (BDUMP), is a rare paraneoplastic eye disorder characterized by abnormal proliferation of melanocytes in the uveal tract. It occurs in association with a malignant tumor elsewhere in the body and can cause significant visual impairment.
The exact mechanism is not fully understood, but immune and tumor-related factors are believed to contribute to the abnormal melanocytic proliferation and associated changes in the eye. Because BDUMP may sometimes precede the diagnosis of the underlying cancer, recognizing its ocular features is important for prompt systemic evaluation and management.
What are the Types of Paraneoplastic Uveal Melanocytic Hyperplasia?
The condition is most accurately described as bilateral diffuse uveal melanocytic proliferation (BDUMP), a rare paraneoplastic syndrome involving diffuse proliferation of uveal melanocytes. Rather than being divided into well-established clinical subtypes, BDUMP is recognized by a characteristic combination of ocular findings.
- Diffuse uveal melanocytic proliferation: Widespread proliferation of melanocytes throughout the uveal tract, often involving both eyes
- Multifocal uveal lesions: Multiple pigmented and non-pigmented melanocytic lesions may develop within the uvea
- Associated retinal changes: Orange-red fundus patches, retinal pigment epithelium abnormalities, and exudative retinal detachment may occur
What are the Symptoms of Paraneoplastic Uveal Melanocytic Hyperplasia?
Paraneoplastic uveal melanocytic hyperplasia can cause progressive visual symptoms, often affecting both eyes. Common manifestations include blurred or decreased vision, visual disturbances, rapidly developing cataracts, and retinal or choroidal changes.
Characteristic ocular findings may include multiple orange-red patches in the fundus, diffuse thickening of the uveal tract, pigmented or non-pigmented uveal lesions, and exudative retinal detachment.
- Blurred or reduced vision
- Floaters or other visual disturbances
- Rapidly progressive cataracts
- Changes in pigmentation or appearance of the retina and uveal tract
- Retinal or choroidal abnormalities, including exudative retinal detachment
Because these symptoms can progress rapidly, unexplained visual changes should be evaluated promptly by an ophthalmologist, particularly when an underlying malignancy is known or suspected.
What are the Causes of Paraneoplastic Uveal Melanocytic Hyperplasia?
Paraneoplastic uveal melanocytic hyperplasia, or BDUMP, develops in association with an underlying systemic malignancy. The exact mechanism responsible for the abnormal proliferation of uveal melanocytes remains uncertain.
It is thought that tumor-related factors and immune mechanisms may stimulate melanocyte proliferation and cause associated damage to ocular tissues. The condition is not considered to be caused by common factors such as sun exposure, GNAQ or GNA11 mutations, or neurofibromatosis type 1.
- Underlying malignancy: Systemic cancers can trigger the paraneoplastic process
- Immune-mediated mechanisms: The immune response to tumor-associated factors may contribute to ocular tissue damage
- Tumor-derived factors: Circulating substances produced by or associated with the malignancy may influence uveal melanocytes
- Uveal melanocyte proliferation: Abnormal proliferation of melanocytes contributes to the characteristic ocular findings
When to See a Doctor?
Seek an oncologist's medical attention for persistent or unexplained changes in vision, especially when symptoms develop rapidly or occur in someone with a known or suspected cancer.
- Blurred or decreased vision
- New floaters or other visual disturbances
- Rapid changes in vision or cataract symptoms
Get medical help immediately if:
- Sudden or severe vision loss
- Rapid worsening of visual symptoms
- New significant visual disturbances affecting daily activities
These symptoms require urgent ophthalmic evaluation to identify the cause and prevent further visual complications.
Find Oncologists for Paraneoplastic Uveal Melanocytic Hyperplasia Treatment Near You
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Hyderabad - Hitech City
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Hyderabad - Financial District
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Secunderabad
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Bengaluru
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Navi Mumbai
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Pune
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Vizag
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Chh.Sambhajinagar
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Nellore
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Kakinada
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Chandanagar
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Nizamabad
- Doctor for Paraneoplastic Uveal Melanocytic Hyperplasia in Srikakulam
How Is Paraneoplastic Uveal Melanocytic Hyperplasia Diagnosed?
Diagnosis involves a detailed ophthalmic examination combined with multimodal ocular imaging and evaluation for an underlying malignancy. The characteristic combination of fundus findings, retinal changes, uveal lesions, and visual symptoms can help identify BDUMP.
- Ophthalmic examination: Evaluates visual acuity and examines the retina, choroid, and uveal tract for characteristic abnormalities
- Fundus photography: Documents orange-red patches and pigmented or non-pigmented uveal lesions
- Optical coherence tomography (OCT): Detects retinal pigment epithelium abnormalities, retinal changes, and subretinal fluid
- Fundus autofluorescence and fluorescein angiography: Help characterize retinal pigment epithelium and vascular changes
- Ocular ultrasonography: Can demonstrate choroidal or uveal thickening
- Systemic evaluation: Imaging and other investigations are performed to identify an underlying malignancy when one has not already been diagnosed
What are the Treatment Options for Paraneoplastic Uveal Melanocytic Hyperplasia?
Treatment of BDUMP focuses primarily on identifying and treating the underlying malignancy while managing the associated ocular complications. Because the condition is rare, there is no standardized treatment protocol, and management is individualized.
- Treatment of the underlying cancer: Surgery, chemotherapy, radiation therapy, or other cancer-directed treatment may be used according to the type and stage of malignancy
- Immunosuppressive therapy: Corticosteroids or other immunomodulatory treatments may be considered to reduce immune-mediated ocular damage
- Plasmapheresis: May be considered in selected patients to remove circulating factors involved in the paraneoplastic process
- Ocular treatment: Treatment of complications such as cataracts or exudative retinal detachment may be required
- Regular monitoring: Ongoing follow-up with ophthalmologists and oncologists is important to monitor vision and the underlying malignancy
Early recognition and systemic evaluation are important because BDUMP can sometimes be the first indication of an otherwise undiagnosed malignancy.
Your health is everything - prioritize your well-being today.
Consult Paraneoplastic Uveal Melanocytic Hyperplasia Doctors Today
What are the Risk Factors of Paraneoplastic Uveal Melanocytic Hyperplasia?
BDUMP is primarily associated with an underlying systemic malignancy rather than traditional ocular risk factors. Several types of cancer have been reported in affected individuals, and ocular manifestations may occasionally appear before the cancer is identified.
- Presence of an underlying systemic malignancy
- Gynecological cancers, including ovarian and uterine cancers
- Lung cancer
- Gastrointestinal cancers
- Other solid tumors, including breast, kidney, pancreatic, and colorectal cancers
Frequently Asked Questions
1. How do I recognize the signs of Paraneoplastic uveal melanocytic hyperplasia?
Look for visual symptoms like blurred vision, floaters, or visual field loss. Seek a doctor's evaluation for proper diagnosis and treatment.
2. How should I care for myself with Paraneoplastic uveal melanocytic hyperplasia�what should I do and avoid?
Follow your doctor's treatment plan, attend regular check-ups, protect your eyes from sunlight, and avoid smoking to manage Paraneoplastic Uveal Melanocytic Hyperplasia.
3. Are there any risks associated with untreated Paraneoplastic uveal melanocytic hyperplasia?
Yes, untreated Paraneoplastic uveal melanocytic hyperplasia can lead to vision loss and potential spread of the underlying cancer to other parts.
4. What are the best ways to manage Paraneoplastic uveal melanocytic hyperplasia?
Treatment includes monitoring for cancer, managing symptoms, and addressing underlying malignancy through surgery, radiation, or chemotherapy.
5. Can Paraneoplastic uveal melanocytic hyperplasia return even after successful treatment?
Yes, Paraneoplastic uveal melanocytic hyperplasia can recur even after successful treatment. Regular monitoring is essential.
